These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinical aspects of hepatolenticular degeneration. Study of the "turnover" of copper in some extrapyramidal syndromes]. Agnoli A; Casacchia M; Fieschi C Recenti Prog Med; 1970 Oct; 49(4):385-98. PubMed ID: 5537615 [No Abstract] [Full Text] [Related]
3. Introduction. Symposium on copper metabolism and Wilson's disease. Goldstein NP; Owen CA Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351 [No Abstract] [Full Text] [Related]
4. [Copper metabolism in hepato-lenticular degeneration thiol therapy]. KONOVALOV NV; MUTTEL'SHTEDT AA; BAUMAN LK; GOTOVTSEVA EV Zh Nevropatol Psikhiatr Im S S Korsakova; 1957; 57(1):39-48. PubMed ID: 13434449 [No Abstract] [Full Text] [Related]
6. [Postural dystonia and spastic torticollis associated with an increase of cupriuria. Relations with hepato-lenticular degeneration]. Fazio C; Agnoli A; Perissinotti E Minerva Med; 1968 Aug; 59(63):3359-68. PubMed ID: 5679202 [No Abstract] [Full Text] [Related]
7. The story of penicillamine: a difficult birth. Walshe JM Mov Disord; 2003 Aug; 18(8):853-9. PubMed ID: 12889074 [No Abstract] [Full Text] [Related]
8. Hepato-lenticular degeneration. (Case report and review of literature). Arora OP; Jain KP; Sobti P J Assoc Physicians India; 1967 Feb; 15(2):79-82. PubMed ID: 6045123 [No Abstract] [Full Text] [Related]
9. [Physiopathology of hepatolenticular degeneration (Wilson's disease)]. Willvonseder R Wien Z Inn Med; 1973; 54(11-12):544-58. PubMed ID: 4804125 [No Abstract] [Full Text] [Related]
10. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine]. D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825 [No Abstract] [Full Text] [Related]
12. The intrahepatic distribution of copper in relation to the pathogenesis of hepatolenticular degeneration. UZMAN LL AMA Arch Pathol; 1957 Oct; 64(4):464-79. PubMed ID: 13457604 [No Abstract] [Full Text] [Related]
13. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease. Falkmer S; Samuelson G; Sjölin S Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388 [No Abstract] [Full Text] [Related]
14. The development of cirrhosis in Wilson's disease. Sternlieb I Clin Gastroenterol; 1975 May; 4(2):367-79. PubMed ID: 1092490 [No Abstract] [Full Text] [Related]
16. The copper-controlled diet: current aspects of dietary copper restriction in management of copper metabolism disorders. Smithgall JM J Am Diet Assoc; 1985 May; 85(5):609-10. PubMed ID: 3886765 [No Abstract] [Full Text] [Related]
19. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease. Marecek Z; Heyrovský A; Volek V Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668 [TBL] [Abstract][Full Text] [Related]
20. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet. Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484 [No Abstract] [Full Text] [Related] [Next] [New Search]